Physician profile
Gregg R Eure
NPI 1316927163
$1,449,078.10
in general payments reported to CMS, 2019-2025
45 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255K · 2020: $164K · 2021: $181K · 2022: $346K · 2023: $339K · 2024: $117K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $348K · Consulting Fee: $98K · Travel and Lodging: $43K · Food and Beverage: $14K · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $348,375.00 |
| Consulting Fee | $97,823.00 |
| Travel and Lodging | $42,902.86 |
| Food and Beverage | $13,812.73 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,019,883.59 | 2020-2025 | Urolift, Barrigel |
| Neotract INC. | $348,149.57 | 2019-2020 | |
| Boston Scientific Corporation | $49,041.88 | 2019-2025 | Greenlight Xps, Axonics, Spaceoar System |
| Sumitomo Pharma America, INC. | $6,580.00 | 2025 | Gemtesa |
| Srs Medical Systems, INC. | $5,172.23 | 2020-2023 | Urocuff |
| Calyxo, INC. | $4,227.81 | 2020-2025 | Cvac Aspiration System |
| Urogpo LLC | $4,165.38 | 2019 | |
| Sn Holdings, LLC | $2,327.38 | 2021-2022 | |
| Uromedica, Incorporated | $1,548.64 | 2019 | |
| Procept Biorobotics Corporation | $1,468.09 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Karl Storz Endoscopy-America | $1,064.82 | 2021-2025 | Autocon |
| Ambu INC. | $685.07 | 2021-2024 | |
| Janssen Biotech, INC. | $578.08 | 2019-2023 | Erleada |
| Dendreon Pharmaceuticals LLC | $476.13 | 2019-2024 | Provenge |
| Astellas Pharma US INC | $430.34 | 2019-2020 |
Show all 44 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$658,989.29 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Eure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.